Credibility Crisis: Survey FDA Scientists – Death in NIH-AIDS Trial – Tauzin Moves to PhRMA

Credibility Crisis:Survey FDA Scientists – Death in NIH-AIDS Trial – Tauzin Moves to PhRMA Thu, 16 Dec 2004 A credibility crisis in medical research is smoldering: like the Enron accounting scandal, the prescription-drug debacle is a matter of systemic corruption, including gross . . . Continue reading →

Pharma Efforts to Bar Placebo Responders from Trials – WSJ

Pharma Efforts to Bar Placebo Responders from Trials – WSJ Fri, 25 Jun 2004 A clinical trial report in The Lancet debunks the value of Aricept, a popular drug prescribed for Alzheimer’s patients. The findings of a three-year placebo controlled trial show . . . Continue reading →

Humbling Reality–Treatments for Depression Often Fail_Boston Globe

The Boston Globe reports (below): “More than 50 years after psychiatrists began widely dispensing drugs to treat mental illness, the profession is coming face to face with a humbling reality: Its treatments often fail, leaving millions of patients [  ] to suffer while doctors search for something that works.”
Continue reading →

Big Pharma: The Fool’s Gold that Heals_New Book

Big Pharma by Jacky Law reveals that in essence, most of the pharmaceutical industry’s claims are false; it is not the drug, but the placebo effect whose potency deserves almost all of the credit for any health improvement:
Continue reading →

NIMH-funded antidepression drug efficacy / safety studies_What do they prove?

Two studies purporting to report “new encouraging” findings about the efficacy and safety of antidepressantsas tested in the “real world”were published on Sunday by The American Journal of Psychiatry with an accompanying editorial by Dr. Thomas Insel, director of these studies’ funding agency, the National Institute of Mental Health.

Continue reading →

NIMH-funded antidepression drug efficacy / safety studies_What do they prove?

Two studies purporting to report “new encouraging” findings about the efficacy and safety of antidepressants were published on Sunday by The American Journal of Psychiatry with an accompanying editorial by Dr. Thomas Insel, director of these studies’ funding agency, the National Institute of Mental Health.
Continue reading →

18% decrease SSRI use in Youth – NYT / Suicide Risk Not New – Globe / Prozac no different

18% decrease SSRI use in Youth – NYT / Suicide Risk Not New – Globe / Prozac no different Tue, 21 Sep 2004 The FDA failed to stop drug manufacturers from flooding the air waves and the scientific literature with false and . . . Continue reading →